News
These Four Leading CROs in Maryland are Driving Success in Life Sciences
Published June 8, 2023
Biotoxtech and CSSi LifeSciences Strengthen Business Cooperation for New Drug Development
Published April 19, 2023
SiSaf’s Innovative RNA Therapeutic for Rare Genetic Skeletal Disorders Begins the U.S. Regulatory Process for Orphan Drug Designation
Published October 12, 2022
CSSi LifeSciences Partners with DevLab Bio to Speed Commercialization of Therapeutic and Medical Device Technologies
Published June 21, 2022
BioCurity Pharmaceuticals Inc. ('BioCurity' or ‘Company’) Announces Presentation at ACRO Summit 2022 on Sensitizing Head and Neck Cancer to Radiation Using the Company’s Cerium Oxide Nanoparticles | Business Wire
Published March 10, 2021
Tonic Bioventures and CSSi LifeSciences Enter Partnership to Form A New Life Sciences Fund
Published January 6, 2021
Ernesto P. Chanona, Ph.D. Joins CSSi LifeSciences As Director of Business Development
Published January 5, 2021